Journal CME Article: Implant-Based Breast Reconstruction: Hot Topics, Controversies, and New Directions
Keyword(s)
Jordan D. Frey MD, Ara A. Salibian MD, Nolan S. Karp MD, Mihye Choi MD, alloplastic, implant-based
Credits
CME:1.0, Patient Safety:0.5
Description
Implant-based, or alloplastic, breast reconstruction is the most common method of breast reconstruction in the United States. Within implant based reconstruction, many techniques and reconstructive strategies exist that must be tailored for each individual patient to yield a successful reconstruction. Not unexpectedly, many hot topics and controversies in this field have emerged, including stages of reconstruction, use of scaffolds, permanent implant type, strategies for post-mastectomy radiation therapy, and antibiotic prophylaxis. In addition, there has been an evolution in technical and device development in recent years. Therefore, plastic surgeons must be on the forefront of knowledge to approach implant-based breast reconstruction in an evidence-based fashion to best treat their patients.
Learning Objectives
After viewing this course, the participant should be able to:
- Evaluate appropriate patients best suited for one- or two-stage alloplastic breast reconstruction.
- Discuss and apply the unique advantages and disadvantages of scaffold use and different implant types in breast reconstruction to maximize outcomes.
- Develop a plan for patients undergoing implant-based breast reconstruction requiring postmastectomy radiation therapy.
- Analyze the evidence with regard to antibiotic prophylaxis in implant-based breast reconstruction.
- Recognize and critique novel technical and device development in the field of alloplastic breast reconstruction, enabling appropriate patient selection.
Faculty
Jordan D. Frey, MD; Ara A. Salibian, MD; Nolan S. Karp, MD; Mihye Choi, MD
Jordan D. Frey, MD; Ara A. Salibian, MD; Nolan S. Karp, MD; Mihye Choi, MD
Plastic and Reconstruction Surgery® Editors:
Editor-in-Chief: Rod J. Rohrich, MD
Co-Editor: James M. Stuzin, MD
Section Editor: Donald H. Lalonde, MD
Editor-in-Chief: Rod J. Rohrich, MD
Co-Editor: James M. Stuzin, MD
Section Editor: Donald H. Lalonde, MD
Accreditation Information
Patient Safety Credit: 0.5
Media: Journal Article, Video
Publish Date: 4/1/2019
Estimated time to complete this course: 1.0 hour
Directly provided by the American Society of Plastic Surgeons® (ASPS®)
Disclosures
Media: Journal Article, Video
Publish Date: 4/1/2019
Estimated time to complete this course: 1.0 hour
Directly provided by the American Society of Plastic Surgeons® (ASPS®)
Accreditation Statement
The American Society of Plastic Surgeons (ASPS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement
The ASPS designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Intended Audience
This educational activity is intended for plastic surgery practitioners, residents, and other healthcare professionals interested in translating expanded knowledge into practice for the improvement of patient outcomes in plastic and reconstructive surgery.
Disclosures
Dr. Rohrich, MD is the Principal/Co-Principal Investigator of research grants awarded to the University of Texas Southwestern Medical Center, Dallas, from Medicis, Mentor, and Contura Pharmaceutical. All research funds are provided directly to UT Southwestern. Dr. Stuzin has no relevant financial relationships or affiliations to disclose. Dr. Lalonde is a consultant for ASSI Instruments. None of the authors have any relevant financial relationships or affiliations to disclose. All ASPS staff members managing this activity have no relevant financial relationships or affiliations to disclose. All identified conflicts of interest have been resolved and the educational content thoroughly vetted by ASPS for fair balance, scientific objectivity, and appropriateness of patient care recommendations. The ASPS also requires faculty/authors to disclose when off-label/unapproved uses of a product are discussed in a CME activity or included in related materials.